Tyra Biosciences, Inc.
TYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $80,077 | $62,518 | $43,008 | $20,636 |
| G&A Expenses | $24,100 | $17,427 | $15,919 | $5,652 |
| SG&A Expenses | $24,100 | $17,427 | $15,919 | $5,652 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $104,177 | $79,945 | $58,927 | $26,288 |
| Operating Income | -$104,177 | -$79,945 | -$58,927 | -$26,288 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $17,696 | $10,811 | $3,602 | -$6 |
| Pre-Tax Income | -$86,481 | -$69,134 | -$55,325 | -$26,294 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$86,481 | -$69,134 | -$55,325 | -$26,294 |
| % Margin | – | – | – | – |
| EPS | -1.51 | -1.62 | -1.23 | -0.63 |
| % Growth | 6.8% | -31.7% | -95.2% | – |
| EPS Diluted | -1.51 | -1.62 | -1.23 | -0.63 |
| Weighted Avg Shares Out | 57,218 | 42,704 | 41,884 | 41,441 |
| Weighted Avg Shares Out Dil | 57,218 | 42,705 | 41,884 | 41,441 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17,696 | $10,811 | $3,652 | $13 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $519 | $357 | $296 | $140 |
| EBITDA | -$103,658 | -$79,588 | -$58,631 | -$26,148 |
| % Margin | – | – | – | – |